BIT:1ROG - CH0012032048 - Common Stock
1ROG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 50 industry peers in the Pharmaceuticals industry. 1ROG gets an excellent profitability rating and is at the same time showing great financial health properties. 1ROG has a valuation in line with the averages, but on the other hand it scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 8.13% | ||
ROE | 26.06% | ||
ROIC | 22.12% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 33.2% | ||
PM (TTM) | 13.68% | ||
GM | 73.91% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.98 | ||
Debt/FCF | 2.3 | ||
Altman-Z | 3.8 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.48 | ||
Quick Ratio | 1.2 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.22 | ||
Fwd PE | 11.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 13.95 | ||
EV/EBITDA | 9.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.77% |
BIT:1ROG (8/22/2025, 7:00:00 PM)
278
+4 (+1.46%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.22 | ||
Fwd PE | 11.75 | ||
P/S | 3.48 | ||
P/FCF | 13.95 | ||
P/OCF | 10.47 | ||
P/B | 6.62 | ||
P/tB | 31.94 | ||
EV/EBITDA | 9.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 8.13% | ||
ROE | 26.06% | ||
ROCE | 26.86% | ||
ROIC | 22.12% | ||
ROICexc | 28.73% | ||
ROICexgc | 50.83% | ||
OM | 33.2% | ||
PM (TTM) | 13.68% | ||
GM | 73.91% | ||
FCFM | 24.94% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.98 | ||
Debt/FCF | 2.3 | ||
Debt/EBITDA | 1.33 | ||
Cap/Depr | 146.33% | ||
Cap/Sales | 8.28% | ||
Interest Coverage | 17.54 | ||
Cash Conversion | 85.47% | ||
Profit Quality | 182.25% | ||
Current Ratio | 1.48 | ||
Quick Ratio | 1.2 | ||
Altman-Z | 3.8 |